neuromedin B (Human) [5654]



neuromedin B (Human)


SMILES CSCCC(NC(=O)C(Cc1ccccc1)NC(=O)C(Cc1cnc[nH]1)NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C(CC(C)C)NC(=O)C(CC(N)=O)NC(=O)CN)C(C)O)C(N)=O
InChIKey YPFNACALNKVZNK-UHFFFAOYSA-N
Sequence GNLWATGHFM
HELM PEPTIDE1{G.(N,[dN]).(L,[dL]).(W,[dW]).(A,[dA]).[*C(=O)C(C(C)O)N* |$_R2;;;;;;;;_R1$|].G.(H,[dH]).(F,[dF]).(M,[dM]).[am]}$$$$V2.0

Chemical Properties

Hydrogen bond acceptors 15
Hydrogen bond donors 15
Rotatable bonds 33
Log P -3.567
Molecular weight (Da) 1131.5
Stereochemistry info unspecified

Database connections

Model (AF2) BB1 BB2
GPCRdb related ligands

Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

neuromedin B (Human)


Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) BB1 BB2
GPCRdb related ligands

Compound is not listed as a drug.